The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125808863 12580886 3 F 20130716 20160824 20160721 20160830 EXP US-PFIZER INC-2013209122 PFIZER 68.00 YR M Y 135.00000 KG 20160830 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125808863 12580886 1 PS IBUPROFEN. IBUPROFEN 1 Oral UNK Y 18989 TABLET
125808863 12580886 2 SS IBUPROFEN. IBUPROFEN 1 Y 18989 TABLET
125808863 12580886 3 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, 1X/DAY 1420 MG Y 0 20 MG QD
125808863 12580886 4 SS LISINOPRIL. LISINOPRIL 1 Oral 40 MG, QD Y 0 40 MG QD
125808863 12580886 5 SS HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 25 MG, QD Y 0 25 MG QD
125808863 12580886 6 SS FUROSEMIDE. FUROSEMIDE 1 Oral 20 MG, QD Y 18667 20 MG QD
125808863 12580886 7 SS SIMVASTATIN. SIMVASTATIN 1 Oral 40 MG, QHS 0 40 MG QD
125808863 12580886 8 C INSULIN GLARGINE INSULIN GLARGINE 1 Intramuscular 60 UNITS, QD 0 60 IU QD
125808863 12580886 9 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 20 MG, QD 0 20 MG QD
125808863 12580886 10 C OXYBUTYNIN OXYBUTYNIN 1 Oral 5 MG, QD 0 5 MG QD
125808863 12580886 11 C CIALIS TADALAFIL 1 Oral 20 MG, PRN 0 20 MG
125808863 12580886 12 C CINNAMON. CINNAMON 1 Oral 2000 MG, QD 0 2000 MG QD
125808863 12580886 13 C PERCOCET ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 Oral 10 MG, PRN 0 10 MG
125808863 12580886 14 C ASPIRIN. ASPIRIN 1 Oral 81 MG, QD 0 81 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125808863 12580886 1 Osteoarthritis
125808863 12580886 2 Rheumatoid arthritis
125808863 12580886 3 Prophylaxis
125808863 12580886 4 Hypertension
125808863 12580886 5 Hypertension
125808863 12580886 6 Oedema
125808863 12580886 7 Dyslipidaemia
125808863 12580886 8 Type 2 diabetes mellitus
125808863 12580886 9 Gastrooesophageal reflux disease
125808863 12580886 10 Urinary incontinence
125808863 12580886 11 Erectile dysfunction
125808863 12580886 12 Medical diet
125808863 12580886 13 Arthralgia
125808863 12580886 14 Cardiovascular event prophylaxis

Outcome of event

Event ID CASEID OUTC COD
125808863 12580886 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125808863 12580886 Acute kidney injury
125808863 12580886 Non-cardiac chest pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125808863 12580886 1 20130507 20130716 0
125808863 12580886 3 20130507 20130716 0
125808863 12580886 4 200301 20130716 0
125808863 12580886 5 200301 20130716 0
125808863 12580886 6 200301 20130716 0
125808863 12580886 7 200301 0
125808863 12580886 8 200301 0
125808863 12580886 9 200301 0
125808863 12580886 10 200801 0
125808863 12580886 11 200801 0
125808863 12580886 12 201202 0
125808863 12580886 13 201303 0
125808863 12580886 14 199801 0